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OligoarginineThe effects of varying the cationic sequence of oligotryptophan-tagged antimicrobial peptides were
investigated in terms of peptide adsorption to model lipid membranes, liposome leakage induction, and
antibacterial potency. Heptamers of lysine (K7) and arginine (R7) were lytic against Escherichia coli bacteria
at low ionic strength. In parallel, both peptides adsorbed on to bilayers formed by E. coli phospholipids, and
caused leakage in the corresponding liposomes. K7 was the more potent of the two peptides in causing
liposome leakage, although the adsorption of this peptide on E. coli membranes was lower than that of R7.
The bactericidal effect, liposome lysis, and membrane adsorption were all substantially reduced at
physiological ionic strength. When a tryptophan pentamer tag was linked to the C-terminal end of these
peptides, substantial peptide adsorption, membrane lysis, and bacterial killing were observed also at high
ionic strength, and also for a peptide of lower cationic charge density (KNKGKKN-W5). Strikingly, the order
of membrane lytic potential of the cationic peptides investigated was reversed when tagged. This and other
aspects of peptide behavior and adsorption, in conjunction with effects on liposomes and bacteria, suggest
that tagged and untagged peptides act by different lytic mechanisms, which to some extent counterbalance
each other. Thus, while the untagged peptides act by generating negative curvature strain in the phospholipid
membrane, the tagged peptides cause positive curvature strain. The tagged heptamer of arginine, R7W5, was
the best candidate for E. coli membrane lysis at physiological salt conditions and proved to be an efﬁcient
antibacterial agent.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionAs a result of increasing occurrence of multidrug-resistant bacteria
in healthcare [1,2], alternative antibiotic drugs are needed. Antimi-
crobial peptides (AMPs) represent promising alternatives in this
respect and are currently receiving much attention due to their rapid
antibiotic effect, broad spectrum [3–5], and apparently moderate
resistance development [6–8]. While the diversity is considerable
among the over 900 antibacterial peptides known, most of them are
cationic and many have amphiphilic characteristics [9]. Most of them
also share the same target of bactericidal action in that they generate
membrane failure in oneway or another [10,11]. Membrane disruption
by AMPs is dependant on the concentration of adsorbed peptide,
although different membrane lipid compositions vary in tolerance
[12–16]. Highly cationic AMPs reach substantial adsorption levels on
the typically anionic membranes of bacteria at low ionic strength.
Since electrostatic driven adsorption is reduced when ionic strength is
increased, these peptides lose much of their potency when in
physiological salt conditions. We therefore previously identiﬁed
end-tagging of AMPs with hydrophobic amino acid stretches as an46 18 4714377.
. Strömstedt).
ll rights reserved.interesting approach in achieving high AMP adsorption and potency at
elevated ionic strengths and also against bacteria with low anionic
charge densities [17–19]. In contrast to the extensive literature on
effects of charge and hydrophobicity on AMP activity, which has
concerned speciﬁc single amino acid substitutions and can thus be
said to be largely sequence speciﬁc, end-tagging by hydrophobic
oligopeptide stretches represents a generally applicable approach for
boosting AMP potencywith limited toxicity. Such end-tagged peptides
are somewhat similar to the acyl-conjugated lipopeptides, such as
Surfactin, Daptomycin, and Polymyxins, which target the bacterial
membrane either directly, causing permeability, or indirectly by
inducing lipid exchange and fusion between the cytoplasmic and
outer membrane [20–24]. These interesting effects of hydrophobic
peptide modiﬁcation, especially the potent bactericidal effects and
striking selectivity previously observed for tryptophan-tagged AMPs
[17–19], give cause for further investigation on the role of the tag and
its template peptide sequence. The cationic template peptides used in
this study were heptamers of lysine or arginine (K7 and R7,
respectively), and KNK7 (KNKGKKN), a peptide sequence from
human kininogen [13,25]. The arginine heptamer also introduced
another aspect of peptide–membrane interactions, since peptides of
this type, but not the corresponding lysine oligomers, have been
reported to be cell penetrating. This cell penetrating attribute seems to
be receptor-independent and consistent for oligoarginines in the size
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this investigation, the cationic peptides, KNK7, K7, and R7, together
with their C-terminal tryptophan pentamer tagged versions,
KNK7W5, K7W5, and R7W5 are studied in terms of peptide
adsorption to bilayers formed by Escherichia coli phospholipids, and
their effects on liposome zeta potential, aggregation, and leakage. This
is correlated with antibacterial action on E. coli and the effect of
varying ionic strength using a combination of ellipsometry, electro-
phoresis, ﬂuorescence spectroscopy, dynamic light scattering, circular
dichroism (CD), and viable count assays.
2. Materials and methods
2.1. Materials
The peptides used in this study were synthesized by Innovagen AB
(Lund, Sweden), with the exception of R7W5 that was from
Biopeptide Co., Inc. (San Diego, CA). The purity (N95%) of these
peptides was conﬁrmed by mass spectrometry analysis (MALDI-ToF
Voyager). The phospholipids used were polar extract of E. coli with a
lipid composition of 67.0% phosphatidylethanolamine (PE), 23.2%
phosphatidylglycerol (PG), and 9.8% diphosphatidylglycerol, obtained
from Avanti Polar Lipids (Alabaster, AL). Triton X-100 and poly-L-
lysine (170 kDa) were obtained from Sigma-Aldrich (St Louis, MO),
while 5(6)-carboxyﬂuorescein (99% purity) was from Acros Organics
(Geel, Belgium). Water used was from a Millipore Milli-Q Plus 185
ultra-pure water system. Other chemicals were of analytical grade. If
not stated otherwise, measurements were performed at 37 °C in
10 mM 2-amino-2-hydroxymethyl-1,3-propanediol (Tris) buffer, pH
7.4 (ionic strength 0.006), when indicated also with 150 mM NaCl
(Tris/NaCl) (ionic strength 0.156).
2.2. Bacteria
The bacterial strain used was E. coli ATCC 25922, from the
American Type Culture Collection (Rockville, MD).
2.3. Liposome preparation
Dry lipid ﬁlms were formed on ﬂask walls by dissolving dry
phospholipids in chloroform to a concentration of 5 g/l, followed by
evaporation under nitrogen gas ﬂow and subsequently placed in
vacuum over night at room temperature. After preparation of the
dried phospholipid ﬁlm, the leakage marker carboxyﬂuorescein was
added at a self-quenching concentration of 100 mM in Tris buffer
(with or without additional 150 mM NaCl), and the lipids were
re-suspended at 50–60 °C while stirring for 30 min. The suspension
was then vortexed and polydispersity was reduced by extrusion
through a polycarbonate ﬁlter of 100 nm pore size using a LipoFast
miniextruder (Avestin, Ottawa, Canada). Non-encapsulated carboxy-
ﬂuorescein was removed by ﬁltration through a Sephadex G-25
Medium PD-10 column (Amersham Biosciences, Uppsala, Sweden).
The resulting liposomes had a mean diameter of 136 nm with a
polydispersity index of 0.23 (measured by dynamic light scattering).
2.4. Liposome leakage
Permeability was measured by monitoring 5(6)-carboxyﬂuores-
cein (Acros Organics, Geel, Belgium) efﬂux from the liposomes to the
external low concentration environment, resulting in loss of self-
quenching and consequently an increased ﬂuorescence signal [28].
The ﬂuorescence increase was measured with a SPEX Fluorolog-2
spectroﬂuorometer (SPEX Industries, Edison, NJ). Measurementswere
conducted, while stirring, at a ﬁxed lipid concentration of 10 μM and
with cumulatively increasing peptide concentrations. In each experi-
ment, an initial signal acquisition for 10min revealed any spontaneousleakage. The effect of each peptide addition to the system was then
monitored for 15 min at which point the initial leakage induction had
largely subsided. To establish the 100% leakage signal, Triton X-100
was added to a concentration of 0.05%.
2.5. Liposome diameter and zeta potential
Liposome mean diameter was determined by dynamic light
scattering, using a Zetasizer Nano ZS (Malvern Instruments, Malvern,
UK), which was also used for zeta potential measurements. The
refractive index used for Tris buffer and carboxyﬂuorescein-free
liposomes were 1.33 and 1.48, respectively. The zeta potential of the
liposomes with or without peptide was measured using disposable
capillary zeta cells and calculated according to the Smoluchowski
model. The lipid concentration was ﬁxed at 50 μM, while peptide
concentrations were varied to correspond to the interval of peptide-
to-lipid ratio where leakage was induced, i.e. from 1:20 to 1:5. All
measurements were performed in triplicate at 22 °C in degassed Tris
buffer after 20 min of peptide incubation. The zeta potential of the
liposomes prior to peptide addition was found to be −41±1 mV,
which is comparable to a previously reported zeta potential of
−48 mV for E. coli bacteria from culture medium conditions [29].
2.6. Ellipsometry
Peptide adsorption to supported lipid bilayers was studied by in
situ null ellipsometry using an Optrel Multiskop ellipsometer (Optrel,
Kleinmachnow, Germany), equipped with a 100 mW argon laser
(532 nm) at an angle of incidence of 67.66°. The adsorption was
monitored by adsorption-induced changes in amplitude and phase of
light reﬂected at the adsorbing surface. From this, the refractive index
and thickness of the adsorbed layer were determined. With these
parameters the adsorbed amount was calculated according to De
Feijter et al. [30], using a refractive index increment of 0.154 cm3/g
[31,32]. Corrections were routinely made to compensate for any
change in bulk refractive index caused by alterations in temperature
or excess electrolyte concentration. The bilayer-supporting surfaces
were polished silica slides with an oxide layer thickness of 30 nm
(Okmetic, Espoo, Finland). These were cleaned for 5 min at 80 °C in
water solutions of 3.6% NH4OH and 4.3% H2O2, followed by 4.6% HCl
and 4.3% H2O2. The slides were then stored in 99.7% ethanol and
cleaned by plasma discharges for 5 min at 18W in 0.2 Torr residual air
prior to use, using a Harrick Plasma Cleaner PDC-32G (Harrick Plasma,
Ithaca, NY). This procedure results in surfaces with an advancing
contact angle against water of less than 10°, and a zeta potential of
−45 mV [33]. The slides where precoated with polylysine (aq) at
25 °C and subsequently washed with Tris buffer. A liposome solution
was prepared in a similar way as that used for leakage experiments
but without carboxyﬂuorescein and with the liposomes subsequently
extruded also through a 30 nm ﬁlter. The lipids were added at a
concentration of 60 μM to the cuvette, and the resulting adsorption
was monitored. After the liposome adsorption and fusion had
stabilized, residual liposomes were removed by rinsing with Tris or
Tris/NaCl buffer. After lipid bilayer formation and adjustments for
buffer and temperature, peptides were added cumulatively, and the
adsorption at each concentration monitored for 45 min (well after
adsorption saturation was reached). Results presented are from
duplicates of separate experiments.
2.7. Viable count
Antibacterial potency of each peptide was determined by viable
count using E. coli bacteria. These were grown to mid-logarithmic
phase in Todd-Hewitt (TH) medium and then washed and diluted in
Tris buffer containing 5mM glucose. Following this, the bacteria (50 μl
with 2×106 cfu/ml) were incubated, for 2 h at 37 °C, with varying
Fig. 1. Peptide-induced leakage of ﬂuorescent marker from E. coli liposomes. The lipid
concentration was ﬁxed at 10 μM while the peptide concentration was cumulatively
increased. Experiments were conducted in 10 mM Tris buffer, pH 7.4, in the absence (a)
or presence (b) of 150 mM NaCl.
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without 150 mMNaCl. Quantiﬁcation of bactericidal activity was done
by counting colony forming units after serial dilutions of the
incubation mixtures, followed by plating on TH agar and incubation
at 37 °C overnight. 100% survival was deﬁned as total survival of
bacteria in the same buffer and under the same condition in the
absence of peptide.
2.8. Circular dichroism
Peptide secondary structure and tryptophan side chain signature
were determined in Tris buffer with or without additional 150 mM
NaCl, as well as in the corresponding liposomal systems (100 μM
lipid). A JASCO J810 spectropolarimeter (JASCO Corporation, Easton,
MD) was used within the 200–260 nm range of at 37 °C, with stirring
in a quartz cuvette at a peptide concentration of 10 μM (16.7 μM for
W3, see below). To avoid any instrumental baseline drift between
measurements, the background value (detected at 260 nm, where no
peptide signal is present) was subtracted for each individual sample
measurement. Signals were also corrected for non-peptide compo-
nents (buffer, electrolyte, liposomes).
2.9. Fluorescence spectra
Tryptophan ﬂuorescence spectra were determined by a SPEX
Fluorolog-2 spectroﬂuorometer. In these experiments, peptide con-
centrations were cumulatively increased from 0.1 to 10 μM. An
excitation wavelength of 280 nmwas used and emission spectra were
taken between 300 and 400 nm. Both λmax and the intensity ratio
between 325 and 355 nm were determined to detect blueshift.
Measurements were conducted at 37 °C while stirring in either Tris or
Tris/NaCl buffer. Where indicated, liposomes (100 μM lipid) were
included, which were incubated with the peptides for 1 h before
measurements were initiated.
3. Results and discussion
3.1. Leakage and adsorption
Longer polymers of lysine and arginine have been found to induce
leakage and fusion in liposomes with mixed zwitterionic/anionic
phospholipids [34]. As can be seen from Fig. 1, E. coli liposome leakage
can also be generated by heptamers of lysine or arginine at low ionic
strength, with K7 being signiﬁcantly more potent than R7. The lytic
activity of these peptides was substantially reduced when the ionic
strength was elevated to physiological conditions, indicating that
electrostatic interaction played a key role in this effect. Peptide
adsorption levels on the corresponding supported bilayer also
indicated that electrostatic interactions played an important role, as
adsorption increases with the charge density of the peptide, and is
drastically reduced at high ionic strength (Fig. 2). However, the
amount of adsorption was not always proportional to the degree of
leakage. Thus, K7 displayed somewhat lower levels of adsorption
compared to R7, yet caused higher leakage induction in the
corresponding liposomes. Although arginine has a higher pKa than
lysine (∼12.5 vs. ∼10.5), which promotes higher adsorption, this only
explains part of the behavior. The delocalized charge of the
guanidinium group of arginine, although highly water soluble, can
be made lipid soluble through ion pairing with anionic lipids, while
amino groups do not show this behavior [35]. As a result of this, short
homopolymers of arginine are efﬁcient cell penetrating peptides, able
to translocate across cell membranes, an ability not shared by
corresponding lysine peptides [36]. If the guanidinium charge is
neutralized to the extent of becoming lipid soluble, the ﬂip-ﬂop
frequency of the peptide would be substantially increased, facilitating
membrane translocation. Due to the zwitterionic nature of themammalian membranes, on which this has primarily been investi-
gated, membrane translocation is accelerated by membrane potential
for the low levels of oligoarginine expected to adsorb [37]. For more
anionic membranes, on the other hand, the higher level of electro-
statically driven adsorption and resulting peptide-generated potential
across the bilayer, together with curvature stress, is expected to
catalyze monolayer translocation independent of potential. The
adsorbed amount of R7 in Fig. 2 could therefore include a sizeable
fraction of peptide localized on the substrate side of the bilayer, which
would result in a higher total adsorption saturation level. Another
factor causing R7 to adsorb to a higher degree than K7 is themaximum
distance between peptide backbone and the cationic charge of the side
chain, which for arginine is 23% greater. This calculated difference has
previously been supported experimentally [38], and would in our case
give the guanidinium ion an increased effective reach of 3.3 Å. When
polycationic peptides adsorb to partially anionic membranes, an
accumulation of anionic lipids in the proximity of the adsorbed
peptide is expected. This results in an entropy penalty that is less
profound for a peptide where the cationic groups are more separated,
contributing to higher adsorption levels for R7. In parallel, introducing
spacers in the peptide backbone or in the side chains of oligoarginines
has shown to increase membrane interaction and cellular uptake
[27,36,39]. The proximity of the cationic groups on K7 would instead
generate a more profound demixing of the anionic and zwitterionic
lipids, a phenomenon that has been described on PE/PG membranes
for short cationic peptides, which causes phase transition due to the
negative curvature contribution of the zwitterionic PE [40]. This effect,
combined with lower peptide ﬂip-ﬂop frequency, would lead to a
Fig. 3. Zeta potential of E. coli liposomes alone or after incubation with peptides at
different concentrations. The concentrations used correspond to peptide-to-lipid ratios
identical to those used in the liposome leakage experiments (Fig. 1a) at 0.5, 1, and 2 μM,
respectively.
Fig. 2. Peptide adsorption monitored by ellipsometry on supported E. coli lipid bilayer.
Peptides were cumulatively added and the adsorption levels quantiﬁed at adsorption
equilibrium. The experiments were conducted in 10 mM Tris buffer, pH 7.4, in the
absence (a) or presence (b) of 150 mM NaCl.
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higher leakage induction by K7.
As can be seen in Fig. 1, the leakage curves more or less ﬂatten
out before reaching 100%. This is in contrast to the leakage curves by
the human cathelicidin, LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLR-
NLVPRTES, net charge+6), a benchmark AMP used here as a standard
for liposome leakage and bactericidal action [41]. Since this saturation
phenomenon has also been observed in DOPE/DOPG (3/1 mol/mol)
systems (results not shown), we believe that any demixing in lipo-
some preparation is not the cause of this effect. This leaves the
possibility of a liposome curvature dependant factor, or alternatively,
when reaching a certain membrane concentration the peptide stabi-
lizes the membrane.
By attaching a tryptophan pentamer tag to the cationic template
peptides KNK7, K7, and R7, the adsorption increases (Fig. 2). The
adsorption levels are similar for all variants and only marginally lower
in the presence of salt. This demonstrates that the tag is the
dominating factor for adsorption of the tagged peptides. In parallel,
liposome leakage is substantial for all tagged peptides, even at high
ionic strength. However, despite the adsorption for the tagged
peptides being essentially the same, R7 W5 is somewhat more potent
in liposome leakage induction than K7W5, which is the opposite of
what is observed for the untagged peptides. Tryptophan is known to
preferentially interact with the bilayer at depths corresponding to the
glyceryl and carbonyl groups that link the alkyl chains to the
phosphatidyl headgroups of the phospholipids [42,43]. This has
been exempliﬁed also in related peptides, where hydrophobic tags
on cationic templates do not penetrate the hydrophobic core when
involving tryptophan [44]. The preference of the tryptophan tag tolocalize close to the headgroup region is also supported by the low
level of blueshift observed in the presence of liposomes (see below).
This preference would factor toward a positive curvature of the
monolayer, and possibly also a reduced ﬂip-ﬂop frequency for the R7
sequence. The former effect would counteract the negative curvature
generated by the cationic sequence, while the latter would make the
membrane more susceptible to curvature strain. The ﬁnding that
R7W5 is more potent than K7W5 in inducing liposome leakage, at
equal adsorbed amounts, suggests that the positive curvature
generated by the tag is the dominant leakage inducing factor rather
than polycationic generated negative curvature. A positive curvature,
as a result of an expanded headgroup region, will lead to membrane
thinning and ultimately membrane failure. This behavior has been
reported for indolicidin, a tryptophan-rich antimicrobial peptide,
when interacting with phospholipid bilayers [45]. The ionic strength
dependence provides further support for the counteracting curvature
effects of the cationic sequence and the tag, where leakage by R7W5
and K7W5 is initiated at lower peptide concentrations when at higher
ionic strength (Fig. 1). Thus, as high ionic strength screens peptide–
lipid electrostatic interactions, the headgroup area generated by the
peptide becomes even larger and results in higher membrane
sensitivity towards these tagged peptides under these conditions.
The zeta potential of the liposomes was highly affected by peptide
addition (Fig. 3), investigated for K7 and R7 and their respective
tagged versions. The concentration intervals used corresponded in
terms of peptide to lipid ratio, with the peptide concentration where
leakage was initiated, i.e. 0.5, 1, and 2 μM of Fig. 1a. Combining these
results with liposome leakage, it seems that leakage is generated
when the potential is reduced above −20 mV. In dynamic light
scattering (Fig. 4), these four peptides showed a moderate effect on
liposome size at low concentrations, whereas at higher concentrations
the untagged peptides caused liposome aggregation while the tagged
peptides did not. This can be linked to the zeta potential of the
liposomes at the respective peptide concentration, where loss of
electrostatic potential and aggregation coincide. Thus, at high
concentrations of K7 W5 and R7W5 the positive potential caused by
the high membrane afﬁnity of the tagged peptides prevents liposome
aggregation that normally accompanies membrane thinning and
curvature strain. This is further substantiated by the aggregates
formed from re-administration of liposomes to these systems, where
oppositely charged liposomes form aggregates with the same
Fig. 5. Circular dichroism spectra of representative peptide systems. The peptide
concentration was 10 μM, except for W3 where a 40% higher concentration was used to
facilitate quantitative comparison of the tryptophan signal with the W5-tagged
peptides. In (a), K7 is representative also for R7 and KNK7 irrespectively of NaCl
presence (150 mM), K7 W5 is representative also for R7W5, KNK7W5, and KNK7W5 in
the presence of NaCl, while K7W5 in the presence of NaCl is representative also for
R7W5 under the same conditions. In (b), W3 is representative also for W3 in the
presence of NaCl, and K7W5 in the presence of liposomes representative for all tagged
peptides in the presence of E. coli liposomes.
Fig. 4.Mean diameter observed by dynamic light scattering on liposomes or aggregates
after 20 min of incubation with each peptide and concentration. The concentrations
used correspond to peptide-to-lipid ratios identical to those used in the liposome
leakage experiments (Fig. 1a) at 0.5, 1, and 2 μM, respectively.
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Such aggregates were observed for all tagged systems, as was
aggregation with K7 and R7, while KNK7 did not seem to affect the
liposomes in any way. In microscopy, these aggregates resembled
neither amyloid ﬁbers nor precipitates formed by cationic peptides
and anionic detergents. Their irregular branching and blistered
appearance instead indicated that ﬂocculation, followed by vesicle
fusion was involved, probably catalyzed by a drive for phase
transformation.
To study the intrinsic effect of the tryptophan pentamer tag itself, a
tryptophan tripeptide (W3), was investigated for comparison. (Longer
oligotryptophan peptides could not be used due to limited aqueous
solubility.) However, W3 did not generate any leakage or aggregation
on its own, nor was it affected by liposome addition in terms of CD or
ﬂuorescence spectra (see below). The reason for this is that it does not
adsorb to the bilayer to any discernable extent (results not shown),
which is due to the higher entropic penalty per residue on adsorption
for these short peptides, in analogy with adsorption of similar
peptides on hydrophobic surfaces [33]. This means that no compar-
able liposome data for W3 could be obtained. Nevertheless, since the
non-lytic KNK7 was rendered highly lytic when tagged, together with
the non-additive effects of tagging on K7 and R7 at low ionic strength,
we conclude that the tryptophan pentamers, as well as the cationic
heptamers are active in lytical processes. This is most strikingly
illustrated by the contrasting effect on K7, where the lytic property at
low ionic strength was reduced when tagged, which supports the
notion of opposed leakage mechanisms.
3.2. Circular dichroism and tryptophan ﬂuorescence
There has been only one previous study, to our knowledge, on the
secondary structure of polytryptophan. It reports α-helical structure
in ethylene glycol monomethyl ether (an intermediary polar solvent),
whichwas also supported by X-ray diffraction in the solid state [46]. In
addition, it was observed that the change in CD spectra on increasing
tryptophan content was not linear, an effect which was attributed to
tryptophan side chain interaction and its effect on optical activity. This
previous reported CD spectrum is not similar to that obtained here for
W3 in Tris buffer (Fig. 5), and neither are previously reported spectra
of glutamyl-tryptophan in water [47]. However, like other aromatic
amino acids, tryptophan has a speciﬁc CD spectrum generated from
the side chain itself, which depends strongly on ambient polarity and
peptide conformation [48]. This means that CD contributions from the
side chains on the peptide's secondary structure are difﬁcult to
deconvolute. While tryptophan residues of many proteins give apositive CD contribution in the region of 220–230 nm [48], W3
displayed a minimum at 224 nm (Fig. 5). Being a tripeptide, it is
reasonable to assume that the spectrum largely represents that of the
side chains, and not of a pronounced secondary structure. KNK7W5,
K7W5, and R7W5 all displayed essentially identical CD spectra in Tris
buffer, with their negative peak at 225 nm. This peak was somewhat
diminished for K7W5 and R7W5 (−18%) and for KNK7 (−7%) upon
NaCl addition to the solvent, while the W3 spectrumwas not affected
(results not shown). This indicates that there are interactions between
the tag and the template sequence that slightly change the micro-
environment around the tryptophan side chains and thus their CD
signal. In the absence of a tryptophan tag, KNK7, K7, and R7 all showed
random coil conﬁguration, irrespective of NaCl or liposome addition.
In the context of cell penetration of oligoarginines, it should be noted
that their membrane-penetrating ability is independent of enantio-
meric substitutions and ordered secondary structure [26,27]. Upon
tagged peptide interaction with E. coli liposomes, the minima of the
tag CD spectra shifts marginally from 225 nm to 229 nm, illustrating
an alteration in indole microenvironment farther from the W3
minima and thus an interaction with the membrane. Due to the
complexity of indole CD spectra interpretation, we refrain from
further elaboration on the details of oligotryptophan interactions with
the bilayer or the cationic template sequence, other than that subtle
CD effects point toward one affecting the other.
Fig. 7. Viable count assay of E. coli incubated with each peptide in Tris buffer in the
absence (a) or presence (b) of 150 mM NaCl. ⁎ indicates a survival of 0%.
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excited at 280 nm, we observed an emissionmaxima (λmax) at 361 nm
for KNK7W5 and at 359 nm for both K7W5 and R7W5. In all other
aspects the emission spectra were virtually identical. In comparison,
W3 displayed a λmax of 362 nm and a somewhat broader peak (Fig. 6).
Upon addition of liposomes to the tagged peptides, a relativelymodest
shift of λmax by −8 nm was observed. No effect of increasing ionic
strength by including 150 mM NaCl could be seen. Again there is only
one previous publication to our knowledge that has dealt with
ﬂuorescence of tryptophan homopolymers, reporting a λmax of
338 nm [49]. However, this previous study included polytryptophan
of up to 25 residues in length, which is difﬁcult to reconcile with the
poor aqueous solubility displayed by tryptophan oligomers longer
than 5 residues. A suspension rather than solution could explain the
redshift observed in this previous investigation when going from
water tomethanol as solvent [49]. The λmax for tryptophan is sensitive
to its local environment and can range from 308 nm (azurin) to
355 nm (glucagons), correlating to the degree of polar solvent
exposure [50]. In general, if the λmax is less than 330 nm, the
tryptophan is in a nonpolar environment, while an emission
maximum above 330 nm indicates a polar environment. However,
the orientation of the polar groups relative to the indole ring
structures also affect the shift in emission spectra [51], since it is the
electric potential across the long axis of the indole rings that dominate
the shift. Water penetration around an adsorbed peptide can vary and
a few water molecules near the faces of the benzene ring can
effectively reduce blueshift, while the shift is only marginally affected
if the edges of the indole group are exposed towater. Ionic groups also
affect the shift, in that a positive charge close to the benzene ring gives
a redshift, while if it is closer to the pyrrole ring it produces a blueshift,
and vice versa for negative charges [51]. Compared with mono-
tryptophan inwater (λmax of 349 nm [49]), the high λmax of the tagged
peptides could be interpreted as a product of cation–π interactions
between the cationic residues and the benzene structure of the
tryptophan residues. However, since theW3 emission spectrum is also
redshifted, it is possible to conclude that; the proximity between the
indole groups themselves gives rise to ﬂuorescence resonance and
thus a higher wavelength emission. The increased width of the W3
spectra compared to the tagged peptides could then be a result of the
increased chain entropy of the tripeptide interfering with indole–
indole resonance. In any case, the results clearly indicate that the
environment around the indole side chains is polar, and only
marginally less so when interacting with the lipid bilayer. Since theFig. 6. Tryptophan ﬂuorescence spectra. The peptide concentrationwas 10 μMexcept for
W3 where a 40% higher concentration was used to facilitate quantitative comparison
with theW5-tagged peptides. The spectra were not affected by the presence of 150 mM
NaCl, but for all tagged peptides there was a shift of−8±0.3 nm upon E. coli liposome
interaction. Both R7W5 spectra are representative also for the respective K7W5 and
KNK7W5 systems, although those of KNK7W5 were shifted by +2 nm.glyceryl/carbonyl region of the bilayer, at which depth tryptophan
previously has been found to preferentially adsorb [42,43], carries a
substantial polarity, the conclusion must be that the tag is also
localized close to the headgroup region. Note also, that we could not
detect any concentration dependant ﬂuorescence shift between 0.1
and 10 μM for the tagged peptides (data not shown), which does not
support peptide aggregation at these concentrations.
3.3. Bactericidal activity
In the viable count assay, bactericidal effect of the peptides
investigated correlated to a large extent with liposome leakage data
(Fig. 7). The non-tagged peptides showed substantial inactivation at
high ionic strength, while salt tolerance was much better for the
tryptophan-tagged peptides. The high antibacterial effect at physio-
logical salt conditions for all tagged peptides indicates the dominating
role of the end-tag for bacterial membrane disruption, which is
comparable with the results observed for the corresponding lipo-
somes. However, there is one major discrepancy between the results
on liposomes and bacteria, displayed by KNK7 that did not generate
liposome leakage, while still being signiﬁcantly antibacterial at low
ionic strength. This suggests that KNK7 is targeting factors other than
the phospholipids membrane. Although we cannot exclude other
potential targets, such as peptidoglycan, lipopolysaccharide, or
membrane proteins, the coinciding effects on liposomes and bacteria
otherwise observed suggest that a major target of the bactericidal
action of these peptides, with the possible exception of KNK7, is the
lipid membrane it self. Antibacterial lipopeptides target the bacterial
membrane, share common features with the present investigated
tagged peptides, and induce positive curvature strain [52]. Similar to
1922 A.A. Strömstedt et al. / Biochimica et Biophysica Acta 1788 (2009) 1916–1923our peptides, they induce leakage simultaneously upon administra-
tion, after which leakage subsides until the concentration is once
again increased [21]. This agrees with a mechanism where leakage is
generated by a selective increase of the area requirements for the
outer monolayer [53]. Transient membrane ruptures created in this
way allow the peptides and lipids to rearrange between the
monolayers and release curvature tension [54]. When this is achieved
the membrane anneals and the leakage stops. In comparison,
detergents with strong hydrophilic heads ﬂip-ﬂop at a slow rate
from the outer to the innermonolayer of a phospholipid bilayer, which
leads to an asymmetrical increase in lateral pressure that bends the
bilayer and causes transient disruption of the membrane at certain
thresholds [55]. This notion of positive curvature strain is consistent
with previous ﬁndings that oligotryptophan-tagged peptides selec-
tively target cholesterol-void membranes [19], and can be attributed
to lateral membrane expansion being opposed by the condensing
effect of cholesterol, as well as to buffering asymmetrical lateral
pressure by its extreme rate of transmembranemovement [56]. As has
been shown in recent publication on tryptophan-tagged peptides, the
tag confers a degree of selectivity toward bacterial membranes
[17–19]. End-tagged variants of proteolytically stable template pep-
tides remain insensitive to degradation by several bacterial proteases
otherwise known to conferAMP resistance [17–19]. TheR7W5peptide,
being the most membrane lytic at physiologic salt conditions and
possibly the most potent candidate as an AMP, might suffer from
enzymatic degradation due to its arginine content. However, since the
activity of the peptides in this study was independent of ordered
secondary structure, substituting L-arginine for the enantiomeric
D-arginine may be a useful approach for protease restriction
[14,57,58]. Similarly, arginases converting arginine to ornithine,
common in wound ﬂuids [59], are also restricted by D-arginine [60].
4. Conclusions
Short oligomers of lysine and arginine are lytic against E. coli
membranes. Although K7 excels in this respect at low ionic strength,
the lytic potency of both oligomers is substantially reduced at
physiological ionic strength. On end-tagging with a tryptophan
pentamer, the lytic properties of both peptides are retained when in
high ionic strength solution, and present also for the lower charge
density template peptide KNK7. The order of membrane lytic potential
for K7 and R7 is reversed when tagged, an aspect that together with
peptide adsorption behavior, suggests that the tagged and untagged
peptides act by different lytic mechanisms that to some extent
counterbalance each other. Thus the tagged peptides induce a positive
curvature strain by increasing the headgroup area, while the untagged
peptides generate negative curvature strain by phase separation of PE.
Since end-tagging had the same general effect on bacterial killing as
on liposome leakage, the results provide new insight into the design of
hydrophobically end-tagged AMPs for achieving high lytic potency.
Acknowledgements
Lotta Wahlberg and Martin Andersson are gratefully acknowl-
edged for technical assistance. We would also like to thank Lovisa
Ringstad, Helena Bysell, and Christian Johansson for fruitful discus-
sions. This work was ﬁnanced by the Swedish Research Council
(projects 13471 and 2006-4469) and DermaGen AB.
References
[1] G.L. French, Clinical impact and relevance of antibiotic resistance, Adv. Drug Deliv.
Rev. 57 (2005) 1514–1527.
[2] G.M. Rossolini, E. Mantengoli, Antimicrobial resistance in Europe and its potential
impact on empirical therapy, Clin. Microbiol. Infect 14 (Suppl. 6) (2008) 2–8.
[3] A.K. Marr, W.J. Gooderham, R.E. Hancock, Antibacterial peptides for therapeutic
use: obstacles and realistic outlook, Curr. Opin. Pharmacol. 6 (2006) 468–472.[4] M. Zasloff, Antimicrobial peptides of multicellular organisms, Nature 415 (2002)
389–395.
[5] R.E. Hancock, H.G. Sahl, Antimicrobial and host-defense peptides as new anti-
infective therapeutic strategies, Nat. Biotechnol. 24 (2006) 1551–1557.
[6] Y. Ge, D.L. MacDonald, K.J. Holroyd, C. Thornsberry, H. Wexler, M. Zasloff, In vitro
antibacterial properties of pexiganan, an analog of magainin, Antimicrob. Agents
Chemother. 43 (1999) 782–788.
[7] V. Nizet, Antimicrobial peptide resistance mechanisms of human bacterial
pathogens, Curr. Issues Mol. Biol. 8 (2006) 11–26.
[8] G.G. Perron, M. Zasloff, G. Bell, Experimental evolution of resistance to an
antimicrobial peptide, Proc. Biol. Sci. 273 (2006) 251–256.
[9] G. Wang, X. Li, Z. Wang, APD2: the updated antimicrobial peptide database and its
application in peptide design, Nucleic. Acids Res. 37 (2009) D933–937.
[10] K.A. Brogden, Antimicrobial peptides: pore formers or metabolic inhibitors in
bacteria? Nat Rev. Microbiol. 3 (2005) 238–250.
[11] Y. Shai, Mode of action of membrane active antimicrobial peptides, Biopolymers
66 (2002) 236–248.
[12] L. Ringstad, E. Andersson Nordahl, A. Schmidtchen, M. Malmsten, Composition
effect on peptide interaction with lipids and bacteria: variants of C3a peptide
CNY21, Biophys. J. 92 (2007) 87–98.
[13] L. Ringstad, L. Kacprzyk, A. Schmidtchen, M. Malmsten, Effects of topology, length,
and charge on the activity of a kininogen-derived peptide on lipidmembranes and
bacteria, Biochim. Biophys. Acta 1768 (2007) 715–727.
[14] A.A. Stromstedt, M. Pasupuleti, A. Schmidtchen, M. Malmsten, Evaluation of
strategies for improving proteolytic resistance of antimicrobial peptides by using
variants of EFK17, an internal segment of LL-37, Antimicrob. Agents Chemother. 53
(2009) 593–602.
[15] A.A. Stromstedt, P. Wessman, L. Ringstad, K. Edwards, M. Malmsten, Effect of lipid
headgroup composition on the interaction between melittin and lipid bilayers,
J. Colloid Interface Sci. 311 (2007) 59–69.
[16] P. Wessman, A.A. Stromstedt, M. Malmsten, K. Edwards, Melittin–lipid bilayer
interactions and the role of cholesterol, Biophys. J. 95 (2008) 4324–4336.
[17] M. Pasupuleti, A. Chalupka, M. Morgelin, A. Schmidtchen, M. Malmsten,
Tryptophan end-tagging of antimicrobial peptides for increased potency against
Pseudomonas aeruginosa, Biochim. Biophys. Acta 1790 (2009) 800–808.
[18] M. Pasupuleti, A. Schmidtchen, A. Chalupka, L. Ringstad, M. Malmsten, End-
tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate
bacterial killing, PLoS ONE 4 (2009) e5285.
[19] A. Schmidtchen, M. Pasupuleti, M. Moumlrgelin, M. Davoudi, J. Alenfall, A.
Chalupka, M. Malmsten, Boosting antimicrobial peptides by hydrophobic
oligopeptide end-tags, J. Biol. Chem. 284 (2009) 17584–17594.
[20] A. Clausell, M. Pujol, M.A. Alsina, Y. Cajal, Inﬂuence of polymyxins on the structural
dynamics of Escherichia coli lipid membranes, Talanta 60 (2003) 225–234.
[21] H. Heerklotz, J. Seelig, Leakage and lysis of lipid membranes induced by the
lipopeptide surfactin, Eur. Biophys. J. 36 (2007) 305–314.
[22] C.C. HsuChen, D.S. Feingold, The mechanism of polymyxin B action and selectivity
toward biologic membranes, Biochemistry 12 (1973) 2105–2111.
[23] J.A. Silverman, N.G. Perlmutter, H.M. Shapiro, Correlation of daptomycin
bactericidal activity and membrane depolarization in Staphylococcus aureus,
Antimicrob. Agents Chemother. 47 (2003) 2538–2544.
[24] A. Liechty, J. Chen, M.K. Jain, Origin of antibacterial stasis by polymyxin B in
Escherichia coli, Biochim. Biophys. Acta 1463 (2000) 55–64.
[25] E.A. Nordahl, V. Rydengard, M. Morgelin, A. Schmidtchen, Domain 5 of high
molecular weight kininogen is antibacterial, J. Biol. Chem. 280 (2005)
34832–34839.
[26] S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, Y. Sugiura, Arginine-
rich peptides. An abundant source of membrane-permeable peptides having
potential as carriers for intracellular protein delivery, J. Biol. Chem. 276 (2001)
5836–5840.
[27] D.J. Mitchell, D.T. Kim, L. Steinman, C.G. Fathman, J.B. Rothbard, Polyarginine
enters cells more efﬁciently than other polycationic homopolymers, J. Pept. Res.
56 (2000) 318–325.
[28] R.F. Chen, J.R. Knutson, Mechanism of ﬂuorescence concentration quenching of
carboxyﬂuorescein in liposomes: energy transfer to nonﬂuorescent dimers, Anal.
Biochem. 172 (1988) 61–77.
[29] K.A. Soni, A.K. Balasubramanian, A. Beskok, S.D. Pillai, Zeta potential of selected
bacteria in drinking water when dead, starved, or exposed to minimal and rich
culture media, Curr. Microbiol. 56 (2008) 93–97.
[30] J.A. De Feijter, J. Benjamins, F.A. Veer, Ellipsometry as a tool to study the adsorption
behavior of synthetic and biopolymers at the air–water interface. Biopolymers 17
(1978) 1759–1772.
[31] F. Tiberg, I. Harwigsson, M. Malmsten, Formation of model lipid bilayers at the
silica–water interface by co-adsorption with non-ionic dodecyl maltoside
surfactant, Eur. Biophys. J. 29 (2000) 196–203.
[32] H.P. Vacklin, F. Tiberg, R.K. Thomas, Formation of supported phospholipid bilayers
via co-adsorption with beta-D-dodecyl maltoside, Biochim. Biophys. Acta 1668
(2005) 17–24.
[33] M. Malmsten, N. Burns, A. Veide, Electrostatic and hydrophobic effects of
oligopeptide insertions on protein adsorption, J. Colloid Interface Sci. 204
(1998) 104–111.
[34] J. Bondeson, R. Sundler, Promotion of acid-induced membrane fusion by basic
peptides. Amino acid and phospholipid speciﬁcities, Biochim. Biophys. Acta 1026
(1990) 186–194.
[35] N. Sakai, S. Matile, Anion-mediated transfer of polyarginine across liquid and
bilayer membranes, J. Am. Chem. Soc. 125 (2003) 14348–14356.
[36] P.A. Wender, D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman, J.B. Rothbard,
1923A.A. Strömstedt et al. / Biochimica et Biophysica Acta 1788 (2009) 1916–1923The design, synthesis, and evaluation of molecules that enable or enhance cellular
uptake: peptoid molecular transporters, Proc. Natl. Acad Sci. U. S. A. 97 (2000)
13003–13008.
[37] J.B. Rothbard, T.C. Jessop, P.A.Wender, Adaptive translocation: the role of hydrogen
bonding and membrane potential in the uptake of guanidinium-rich transporters
into cells, Adv. Drug Deliv. Rev. 57 (2005) 495–504.
[38] L. Sun, O.A. Groover, J.M. Canﬁeld, K. Warncke, Critical role of arginine 160 of the
EutB protein subunit for active site structure and radical catalysis in coenzyme B12-
dependent ethanolamine ammonia-lyase, Biochemistry 47 (2008) 5523–5535.
[39] J.B. Rothbard, E. Kreider, C.L. VanDeusen, L. Wright, B.L. Wylie, P.A. Wender,
Arginine-rich molecular transporters for drug delivery: role of backbone spacing
in cellular uptake, J. Med. Chem. 45 (2002) 3612–3618.
[40] A. Arouri, M. Dathe, A. Blume, Peptide induced demixing in PG/PE lipid mixtures:
a mechanism for the speciﬁcity of antimicrobial peptides towards bacterial
membranes? Biochim. Biophys. Acta (2008).
[41] U.H. Durr, U.S. Sudheendra, A. Ramamoorthy, LL-37, the only human member of
the cathelicidin family of antimicrobial peptides, Biochim. Biophys. Acta 1758
(2006) 1408–1425.
[42] W.M. Yau, W.C. Wimley, K. Gawrisch, S.H. White, The preference of tryptophan for
membrane interfaces, Biochemistry 37 (1998) 14713–14718.
[43] M.R. de Planque, B.B. Bonev, J.A. Demmers, D.V. Greathouse, R.E. Koeppe, F.
Separovic, A. Watts, J.A. Killian, Interfacial anchor properties of tryptophan
residues in transmembrane peptides can dominate over hydrophobic matching
effects in peptide-lipid interactions, Biochemistry 42 (2003) 5341–5348.
[44] E. Glukhov, M. Stark, L.L. Burrows, C.M. Deber, Basis for selectivity of cationic
antimicrobial peptides for bacterial versus mammalian membranes, J. Biol. Chem.
280 (2005) 33960–33967.
[45] H.J. Askou, R.N. Jakobsen, P. Fojan, An atomic force microscopy study of the
interactions between indolicidin and supported planar bilayers, J. Nanosci.
Nanotechnol. 8 (2008) 4360–4369.
[46] E. Peggion, A. Cosani, A.S. Verdini, A. Del Pra,M.Mammi, Conformational studies on
poly-L-tryptophan: circular dichroism andX-ray diffraction studies, Biopolymers 6
(1968) 1477–1486.[47] S. Brahms, J. Brahms, Determination of protein secondary structure in solution by
vacuum ultraviolet circular dichroism, J. Mol. Biol. 138 (1980) 149–178.
[48] R.W.Woody, Contributions of tryptophan side chains to the far-ultraviolet circular
dichroism of proteins, Eur. Biophys. J. 23 (1994) 253–262.
[49] K. Lotte, R. Plessow, A. Brockhinke, Static and time-resolved ﬂuorescence
investigations of tryptophan analogues—a solvent study, Photochem. Photobiol.
Sci. 3 (2004) 348–359.
[50] M.R. Eftink, Fluorescence techniques for studying protein structure, Methods
Biochem. Anal 35 (1991) 127–205.
[51] J.T. Vivian, P.R. Callis, Mechanisms of tryptophan ﬂuorescence shifts in proteins,
Biophys. J. 80 (2001) 2093–2109.
[52] S. Thennarasu, D.K. Lee, A. Tan, U. Prasad Kari, A. Ramamoorthy, Antimicrobial
activity and membrane selective interactions of a synthetic lipopeptide MSI-843,
Biochim. Biophys. Acta 1711 (2005) 49–58.
[53] M.P. Sheetz, S.J. Singer, Biological membranes as bilayer couples. A molecular
mechanism of drug–erythrocyte interactions, Proc. Natl. Acad Sci. U. S. A. 71
(1974) 4457–4461.
[54] A.A. Gurtovenko, O.I. Onike, J. Anwar, Chemically induced phospholipid
translocation across biological membranes, Langmuir 24 (2008) 9656–9660.
[55] U. Kragh-Hansen, M. le Maire, J.V. Moller, The mechanism of detergent
solubilization of liposomes and protein-containing membranes, Biophys. J. 75
(1998) 2932–2946.
[56] Y. Lange, J. Dolde, T.L. Steck, The rate of transmembrane movement of cholesterol
in the human erythrocyte, J. Biol. Chem. 256 (1981) 5321–5323.
[57] R. Bessalle, A. Kapitkovsky, A. Gorea, I. Shalit, M. Fridkin, All-D-magainin: chirality,
antimicrobial activity and proteolytic resistance, FEBS Lett. 274 (1990) 151–155.
[58] S.Y. Hong, J.E. Oh, K.H. Lee, Effect of D-amino acid substitution on the stability, the
secondary structure, and the activity of membrane-active peptide, Biochem.
Pharmacol. 58 (1999) 1775–1780.
[59] J.E. Albina, C.D. Mills, A. Barbul, C.E. Thirkill, W.L. Henry, B. Mastrofrancesco, M.D.
Caldwell, Arginine metabolism in wounds, Am. J. Physiol. 254 (1988) E459–467.
[60] R.S. Reczkowski, D.E. Ash, Rat liver arginase: kinetic mechanism, alternate
substrates, and inhibitors, Arch. Biochem. Biophys. 312 (1994) 31–37.
